Editorial: EU must rethink vaccine strategy after its misstep

By underestimating the logistics of a mass vaccination rollout, European leaders risk failing their citizens on this vital issue

AstraZeneca got into a row with the US Food and Drug Administration over the conduct of a clinical trial

AstraZeneca has made few friends in the weeks since it unveiled a Covid-19 vaccine along with Oxford University. Since that joint achievement, the vaccine has been clouded by doubts, and an impression that the Anglo-Swedish pharmaceutical company’s focus is as much on the stock market as on the pandemic.

During testing of the vaccine, AstraZeneca got into a row with the US Food and Drug Administration over the conduct of a clinical trial. German scientists ...